Skip to content

MREO - Mereo BioPharma Group plc - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchM

Mereo BioPharma Group PLC ADR

MREO · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

M

MREOMereo BioPharma Group PLC ADR

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $2.37
52-wk low: $0.20
Prev close: $1.19
Mkt cap: $49.7M
Beta: 0.30
P/S: 97.5x

Smart money

8 funds hold a position.

Real smart money

Funds holding this stock

8 holders

Combined position$7.5M

SC
Schonfeld
Steven Schonfeld · Q4 2025 13F
$2.5M
position
MI
Millennium
Israel Englander · Q1 2026 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $50M

Valuation

P/S97.53
P/B1.75

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: MREO
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $49.74M
Beta: 0.30

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

1.8x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-67.8%

$1.2M

position

BA

Balyasny

Dmitry Balyasny · Q4 2025 13F

$533K

position

5 more holders

Lite opens all of them for $16.50/month, paid yearly.

Unlock all 5 holders

Coverage gaps for MREO

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-67.8%

ROA-42.5%

Growth

Beta0.30